Pathogen-specific clinical and inflammatory phenotypes in pediatric catheter-related infections

Merve Özden Budağ1, Tugce Tural-Kara2

  • 1Department of Pediatrics, Akdeniz University Hospital, Antalya, Turkey.

Insights

Early management of pediatric catheter-related infections (CRI) is challenging. While pathogen-specific inflammatory profiles exist, individual biomarkers have modest discriminatory power for guiding empirical therapy without further validation.

Area of Science:

  • Pediatric Infectious Diseases
  • Clinical Microbiology
  • Biomarker Research

Background:

  • Pediatric catheter-related infections (CRI) are common in children with hematologic/oncologic disorders, often presenting non-specifically.
  • Delayed microbiological confirmation necessitates empirical therapy, with increasing reports of Gram-negative and fungal pathogens alongside predominant Gram-positive organisms.
  • Current inflammatory biomarkers (e.g., CRP, procalcitonin) have equivocal capacity to differentiate CRI pathogen classes.

Purpose of the Study:

  • To investigate pathogen-specific clinical and inflammatory profiles in pediatric CRI.
  • To assess the discriminatory capacity of biomarkers for differentiating Gram-negative, Gram-positive, and fungal CRI.
  • To evaluate the utility of these profiles for contextual risk assessment at initial clinical suspicion.

Main Methods:

  • Retrospective single-center cohort study of 291 CRI episodes in 177 pediatric patients (March 2020-February 2024).
  • Analysis of clinical variables at catheter insertion and inflammatory biomarkers (CRP, PCT, NLR, lymphocyte count) at infection onset.
  • Multivariable logistic regression models used to identify predictors of Gram-negative vs. Gram-positive and fungal vs. bacterial CRI.

Main Results:

  • Incidence density of CRI was 11.7 per 1000 catheter days; pathogens identified in 94.2% of episodes (51.1% Gram-positive, 40.5% Gram-negative, 8.4% fungal).
  • Gram-negative CRI associated with higher CRP, PCT, and NLR levels; PCT showed highest discrimination for Gram-negative CRI (AUC 0.663).
  • Lymphocyte count demonstrated moderate discrimination for fungal CRI (AUC 0.711); individual biomarker discrimination was modest.

Conclusions:

  • Pediatric CRI exhibit distinct pathogen-associated inflammatory and device-related patterns.
  • Individual biomarker performance for differentiating CRI pathogens is modest.
  • Findings support contextual risk assessment but require prospective validation before altering guideline-based empirical therapy.

Related Concept Videos

Urinary Tract Infection II: Pathophysiology01:25

Urinary Tract Infection II: Pathophysiology

The pathophysiology of urinary tract infections (UTIs) encompasses several progressive stages, beginning with bacterial colonization and culminating in potential systemic complications if untreated. UTIs are primarily initiated by bacteria, such as Escherichia coli, which often originate from the gastrointestinal tract and migrate to the urinary system through the periurethral area. This migration can occur via several routes, including improper hygiene practices, sexual activity, or...
Determinants of Bacterial Pathogenicity and Virulence01:20

Determinants of Bacterial Pathogenicity and Virulence

Pathogenic bacteria employ a variety of strategies to establish infections, including the secretion of extracellular enzymes that act as potent virulence factors. These enzymes facilitate bacterial colonization of host tissues and help evade immune surveillance. By targeting structural components of host tissues and interfering with immune mechanisms, these enzymes play a pivotal role in disease progression.Extracellular Enzymes Facilitating Tissue Invasion: Several bacterial pathogens secrete...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic01:26

Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic

Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...